| Completed | An Open-Label Study of XOMA 358 in Patients With Hypoglycemia After Gastric Bypass Surgery Hypoglycemia | Phase 2 | 2016-04-01 |
| Completed | A Single-Dose Open-Label Study of XOMA 358 in Subjects With Congenital Hyperinsulinism Congenital Hyperinsulinism | Phase 2 | 2015-10-01 |
| Terminated | An Efficacy and Safety Study of Gevokizumab in Treating Active Ulcers of Pyoderma Gangrenosum Pyoderma Gangrenosum | Phase 3 | 2014-12-01 |
| Terminated | Efficacy and Safety Study of Gevokizumab to Treat Behcet's Disease Uveitis Behcet's Disease Uveitis | Phase 3 | 2014-11-01 |
| Terminated | An Efficacy and Safety Study of Gevokizumab in Treating Active Ulcers of Pyoderma Gangrenosum Pyoderma Gangrenosum | Phase 3 | 2014-11-01 |
| Terminated | A 2-Year, Open-Label, Safety Extension Study of Gevokizumab in Subjects With Pyoderma Gangrenosum Pyoderma Gangrenosum | Phase 3 | 2014-11-01 |
| Terminated | An Open-label, Rollover Study Providing Continued Dosing of Gevokizumab in Order to Assess Long-term Gevokizum Uveitis | Phase 3 | 2014-03-01 |
| Completed | The Effects of Gevokizumab in Corticosteroid-resistant Subjects With Autoimmune Inner Ear Disease Autoimmune Inner Ear Disease | Phase 2 | 2013-08-01 |
| Completed | Safety and Biologic Activity Study of Gevokizumab to Treat Erosive Osteoarthritis of the Hand Osteoarthritis | Phase 2 | 2013-05-01 |
| Completed | Proof of Concept Study of Gevokizumab in the Treatment of Pyoderma Gangrenosum Pyoderma Gangrenosum | Phase 2 | 2013-05-01 |
| Completed | Open-label Safety Extension Study of Gevokizumab in Erosive Osteoarthritis of the Hand Osteoarthritis | N/A | 2013-03-01 |
| Terminated | Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment Uveitis | Phase 3 | 2012-10-01 |
| Terminated | Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis Uveitis | Phase 3 | 2012-08-01 |
| Completed | Safety and Biologic Activity Study of Gevokizumab to Treat Erosive Osteoarthritis of the Hand Osteoarthritis | Phase 2 | 2012-07-01 |
| Completed | Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris Acne Vulgaris | Phase 2 | 2011-12-01 |
| Completed | Study of the Safety and Biologic Activity of XOMA 052 in Subjects With Type 2 Diabetes Mellitus Type 2 Diabetes Mellitus | Phase 2 | 2010-05-01 |
| Completed | Study of the Effects of XOMA 052 on Insulin Production in Subjects With Well Controlled Type 1 Diabetes Type 1 Diabetes | Phase 2 | 2010-02-01 |
| Completed | Safety and Efficacy of XOMA 052 in Subjects With Type 2 Diabetes Mellitus on Stable Metformin Monotherapy Type 2 Diabetes Mellitus | Phase 2 | 2010-01-01 |
| Suspended | Safety and Pharmacokinetics Study of XOMA 052 in Subjects With Active, Stable, Moderate to Severe Rheumatoid A Rheumatoid Arthritis | Phase 2 | 2009-02-01 |
| Completed | Single-dose, Dose-escalation Study of Safety, PK, and Preliminary Efficacy of XOMA 052 in Type 2 Diabetes Mell Type 2 Diabetes | Phase 1 | 2007-09-01 |
| Completed | Safety and Pharmacokinetics Study of XOMA 052 in Subjects With Type 2 Diabetes Mellitus Type 2 Diabetes | Phase 1 / Phase 2 | 2007-07-01 |
| Terminated | Study of Opebacan in Patients Undergoing Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSC Graft Versus Host Disease | Phase 1 / Phase 2 | 2007-02-01 |
| Completed | Phase I Study of a Monoclonal Antibody for Treatment of Advanced Adenocarcinomas Adenocarcinoma | Phase 1 | 2002-07-01 |
| Completed | Safety and Efficacy of a Monoclonal Antibody for Treatment of Rheumatoid Arthritis. Rheumatoid Arthritis | Phase 2 | 2002-04-01 |
| Completed | Safety, Efficacy and Pharmacokinetics of an Antibody for Psoriatic Arthritis Psoriatic Arthritis | Phase 1 | — |